145 related articles for article (PubMed ID: 10951153)
1. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
Davison SC; Morris-Jones R; Powles AV; Fry L
Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153
[TBL] [Abstract][Full Text] [Related]
2. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
Pedraz J; Daudén E; Delgado-Jiménez Y; García-Río I; García-Díez A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
[TBL] [Abstract][Full Text] [Related]
3. Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis.
Ameen M; Smith HR; Barker JN
Clin Exp Dermatol; 2001 Sep; 26(6):480-3. PubMed ID: 11678869
[TBL] [Abstract][Full Text] [Related]
4. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
Hrvacević R; Ignjatović Lj; Vavić N; Dimitrijević J; Drasković-Pavlović B; Dujić A; Elaković D; Kronja G; Marić M
Vojnosanit Pregl; 2001; 58(2):157-60. PubMed ID: 11475669
[TBL] [Abstract][Full Text] [Related]
5. The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management.
François H; Dürrbach A; Amor M; Djeffal R; Kriaa F; Paradis V; Bedossa P; Charpentier B
Nephrol Dial Transplant; 2003 Sep; 18(9):1909-16. PubMed ID: 12937242
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
Geilen CC; Arnold M; Orfanos CE
Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
Buell C; Koo J
J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
Haufs MG; Beissert S; Grabbe S; Schütte B; Luger TA
Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.
Lim AK; Donnan G; Chambers B; Ierino FL
Intern Med J; 2007 Jan; 37(1):55-9. PubMed ID: 17199845
[TBL] [Abstract][Full Text] [Related]
10. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
Daudén E; Sánchez-Peinado C; Ruiz-Genao D; García-F-Villalta M; Onate MJ; García-Díez A
Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
[TBL] [Abstract][Full Text] [Related]
11. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
Beissert S; Pauser S; Sticherling M; Frieling U; Loske KD; Frosch PJ; Haase I; Luger TA
Dermatology; 2009; 219(2):126-32. PubMed ID: 19546522
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction.
Koch RO; Graziadei IW; Schulz F; Nachbaur K; Königsrainer A; Margreiter R; Vogel W
Transpl Int; 2004 Oct; 17(9):518-24. PubMed ID: 15365603
[TBL] [Abstract][Full Text] [Related]
13. Renal function after 10 years' treatment with cyclosporin for psoriasis.
Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
Zhou Y; Rosenthal D; Dutz J; Ho V
J Cutan Med Surg; 2003; 7(3):193-7. PubMed ID: 12704533
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
Grundmann-Kollmann M; Mooser G; Schraeder P; Zollner T; Kaskel P; Ochsendorf F; Boehncke WH; Kerscher M; Kaufmann R; Peter RU
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
[TBL] [Abstract][Full Text] [Related]
16. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study.
Potena L; Prestinenzi P; Bianchi IG; Masetti M; Romani P; Magnani G; Fallani F; Coccolo F; Russo A; Ponticelli C; Rapezzi C; Grigioni F; Branzi A
J Heart Lung Transplant; 2012 Jun; 31(6):565-70. PubMed ID: 22341702
[TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy.
Lecornu-Heuze L; Ducloux D; Rebibou JM; Martin L; Billerey C; Chalopin JM
Nephrol Dial Transplant; 1998 Dec; 13(12):3212-3. PubMed ID: 9870494
[No Abstract] [Full Text] [Related]
20. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.
Reitamo S; Spuls P; Sassolas B; Lahfa M; Claudy A; Griffiths CE;
Br J Dermatol; 2001 Sep; 145(3):438-45. PubMed ID: 11531834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
